In this issue:
Radiographic and endoscopic screening to reduce gastric cancer mortality
Liquid biopsy signature for early gastric cancer detection
Molecular vs. susceptibility testing-guided H. pylori eradication therapy
Predicting intragastric rifabutin concentrations in H. pylori treatment
Hybrid, high-dose dual and bismuth quad therapies for first-line H. pylori treatment
Impact of delayed screening invitations on screen-detected/interval CRCs
Synchronous neoplasia at diagnosis of early- vs. average-onset CRC
Daily low-volume paracentesis and clinical complications in refractory ascites
Immunomodulators and cervical neoplasia risk in women with IBD
PPI use increases gastric polyp risk
Please login below to download this issue (PDF)